Oct 25, 2019 09:54AM
Oct 25, 2019 09:54AM
Feb 25, 2019 09:25AM
Feb 25, 2019 01:00AM
Feb 19, 2019 07:30AM
Feb 19, 2019 07:30AM
Jan 31, 2019 07:48AM Spark Therapeutics (ONCE) Plans Presentation of Preclinical Data in Pompe Disease and CLN2 Disease at WORLDSymposium
Jan 31, 2019 07:30AM
Jan 31, 2019 07:30AM
Dec 3, 2018 05:54AM
Dec 2, 2018 07:30PM
Dec 2, 2018 07:30PM
Nov 23, 2018 05:48AM
Nov 23, 2018 01:15AM European Commission Approves Spark Therapeutics’ LUXTURNA® (voretigene neparvovec), a One-time Gene Therapy for Inherited Retinal Disease Caused by Confirmed Biallelic RPE65 Mutations
Nov 23, 2018 01:15AM
Nov 21, 2018 01:13AM
Nov 6, 2018 07:30AM
Nov 6, 2018 07:30AM
Oct 30, 2018 07:30AM
Oct 30, 2018 07:30AM
Oct 29, 2018 04:55PM Spark Therapeutics (ONCE) Delivers Three Post-hoc Analyses from Phase 3 Clinical Trial of LUXTURNA (voretigene neparvovec-rzyl)
Oct 29, 2018 04:53PM
Oct 29, 2018 04:53PM
Oct 25, 2018 07:30AM
Oct 25, 2018 07:30AM
Oct 8, 2018 07:31AM
Oct 8, 2018 07:30AM
Oct 8, 2018 07:30AM Spark Therapeutics Announces New Preclinical Data for Pompe Disease Gene Therapy Candidate
Oct 3, 2018 02:03AM
Sep 21, 2018 07:18AM
Sep 21, 2018 07:17AM
Sep 21, 2018 07:17AM
Aug 7, 2018 09:20AM
Aug 7, 2018 07:30AM
Aug 7, 2018 07:30AM Spark Therapeutics Reports Second Quarter 2018 Financial Results and Recent Business Progress
Aug 3, 2018 07:30AM
Aug 3, 2018 07:30AM
Jul 31, 2018 07:30AM
Jul 31, 2018 07:30AM
Jul 16, 2018 10:31AM
Jul 16, 2018 10:31AM
May 22, 2018 12:48PM uniQure (QURE), Others Gains Following Gottlieb Comments on Gene Therapy
May 22, 2018 12:45PM
May 22, 2018 05:51AM
May 22, 2018 02:00AM
May 22, 2018 02:00AM
May 22, 2018 02:00AM
May 8, 2018 07:30AM
May 8, 2018 07:30AM Spark Therapeutics Reports First Quarter 2018 Financial Results and Recent Business Progress
May 1, 2018 07:30AM

322,084 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All